Interim Information. January - September 2015.

|       Interim Information January 1 – September 30 2015.

  • Operating revenues totaled MSEK 1.583 (MSEK 1.233).
  • Profit/loss after financial items totaled MSEK -6.435 (MSEK -5.802).
  • Earnings per share before dilution: SEK -0.24.
  • Earnings per share after dilution: SEK -0.24.

|       Financial calendar.

Year-end report for 2015: 2016-02-19.

Annual Report 2015: 2016-03-24.

Interim information January-March 2016: 2016-05-20.

Half-Year Report January-June 2016: 2016-08-26.

Interim information January-September 2016: 2016-11-25.

|       Significant events during the period.

  • 2015-01-15 – Remium Nordic assumes the role as Certified Adviser.
  • 2015-01-26 – Brighter extends its network with Doc. Michael Alvarsson as an advisor.
  • 2015-02-06 - Brighter cancels the launch of Brighter One. The Board is investigating the options available to recover development costs from its development partner.
  • 2015-02-10 – Brighter presents damage claims against its earlier development partner.
  • 2015-02-20 – Brighter selects Veryday as its industrial design partner.
  • 2015-03-16 – Brighter selects Helbling as its design & development partner.
  • The Board of Directors has taken steps to ensure the financing of the Company.
  • 2015-03-26 – Brighter publishes press release about collaboration with Microsoft in e- and m-health.
  • 2015-03-30 – Brighter secures loan of 3 MSEK.
  • 2015-03-30 – Brighter decides to undertake a rights issue with an overallotment issue.
  • 2015-04-17 – Brighter publishes a memorandum regarding the upcoming rights issue totaling MSEK 16.3.
  • 2015-04-24 – Brighter informs the market that PRV, The Swedish Patent and Registration Office, intends to grant Brighter patent for the unique injection technique that will be used in Actiste.
  • 2015-04-27 – Brighter informs the market that the company is expanding its global protection.
  • 2015-05-08 – Brighter informs the market that the rights issue has been oversubscribed with 1,219%. The company has raised a total of MSEK 19.3 before issuing costs. 
  • 2015-05-27 – Brighter publishes the annual report for 2014.
  • 2015-07-03 – Brighter launches Go Diabetes – a news app for diabetics.
  • 2015-08-26 – Brighter communicates that it has filed a lawsuit against its former development partner HotSwap AB.
  • 2015-09-21 – Brighter acquires the company behind jDome BikeAround.

|       Significant events after the end of the period.

  • 2015-10-05 - Brighter and Ericsson in cooperation on technology and business development in mHealth.
  • 2015-10-22 – Strong increase in sales of Brighter’s jDome products.
  • 2015-11-23 – ”Brighter One” becomes ”Actiste”.
  • 2015-11-30 – Recalculation of warrants Serie 2011/2014 and 2013/2016.
  • Warrants Serie 2011/2014 and Serie 2013/2016 subscription period is 2015-11-01 to 2016-01-31. 100% of Serie 2011/2014 has been subscribed and paid for, amounting to approx. MSEK 2.6. 33% of Serie 2013/2016 has been subscribed and paid for, amounting to approx. MSEK 2.8. 1,945,141 shares will be registered, subject to further subscription and registration, as the subscription period running through 2016-01-31. This strengthens Brighter’s cash by approx. MSEK 5.4.

|       Message from the CEO.

The third quarter was marked by change, development and above all a lot of new opportunities that we are extremely happy about. In addition to the mobile service Go Diabetes, we are particularly pleased with the acquisition of the jDome® technology that proved to be very popular and well liked. We have since the acquisition in late September seen a fantastic fast growth in sales in the jDome segment, and interest from potential buyers and users since then has been far beyond expectations.

Through the acquisition of the company behind the jDome technology, we not only got smart, nice, dedicated and driven people but also broadened our IP and product portfolio in new sought after areas that are important in Brighter’s vision of a data-driven healthcare. Big data is hotter than ever and we at Brighter see great opportunities to streamline and improve the care, treatment and development through analysis and re-use of the personal data that our products collect.

Brighter stronger focus on online healthcare and data analysis contributes to the company's products, jDome and now Actiste after the name change from Brighter One, creating greater value on multiple levels. Partly due to that the user's direct care can be improved by specific adjustments, but also because it can contribute to new insights for researchers and developers. At the same time, the entire continuum of care becomes more efficient through easy access to continuous data and automatic mobile contact with patients.

In October, we entered into a partnership with Ericsson, which is an important and historic milestone for the company. The cooperation brings Brighter closer than ever to becoming a key player in the global market for mobile healthcare and connected care units. Through the partnership with Ericsson and local mobile network operators The Benefit Loop gets all the necessary components for incorporating Brighter's vision of a globally connected healthcare chain, where the patient is in focus.

We continue to develop Actiste rapidly and simultaneously take advantage of the opportunities jDome contributes continuously. Looking ahead, one of our main objectives is to find launch partners in various parts of the world, currently our and Ericsson's focus is in Asia, in order to carry out a broad global commercialization of our products and services through The Benefit Loop.

Finally, I want to personally thank our shareholders who accompany us on this amazing journey to the future of healthcare. We have received many new owners during the past quarter, from various parts of the world, and we will work hard to create value for both old and new owners.

Truls Sjöstedt

CEO Brighter AB (publ).

|       Investments.

The Company's investments consist mainly of capitalization of development expenses - both external and internal - and patents. During the period January to September 2015 the Company resumed capitalization of development expenses associated with the development of Actiste and the Benefit Loop. During the period investments amounted to MSEK 9.4 (11.2).

Capitalized expenses for research and development, equipment and tools, installations on third party property at the end of the period amounted to MSEK 14.5. This mainly refers to the development of Actiste and the Benefit Loop.

2015-09-18 Brighter contracted with the main shareholders of Division By Zero AB to acquire more than 90% of the shares in Division By Zero. 2015-10-08 the registration of the non-cash issue regarding this acquisition was completed, resulting in an increased number of issued shares to 35,380,431. The value of the acquisition, calculated on the average price 2015-09-18, and given that the Brighter by its offer to the minority shareholders, gains control of 100% of the shares in Division by Zero, now Brighter Two AB, would be about MSEK 7.7, the total number of issued shares amounts to 2,615,279. Brighter has filed for registration of received minority shareholders shares, corresponding to approximately 9% of the shares in Brighter Two AB, meaning Brighter will have control over more than 99% of the shares. There remain a small number of shares that Brighter intends to gain control over shortly.

|       Risks.

Risks relating to the operation are described in the Annual Report for the fiscal year 2014 and also in the offering memorandum from April 2015 (Swedish only).

|       Financial position.

Cash on September 30 2015 amounted to approx. MSEK 5.4 (8.5).

The Company’s equity amounted to MSEK 19.8 (26.6), affected by the rights issue in April 2015 and the loss reported for 2014.

In April and May 2015 the Company executed two unit issues, which brought an additional MSEK 19.3 in capital before deduction of issuing expenses. The Company took a loan of MSEK 3 during the issuing period, which was then repaid from the raised funds.

In November 2015 1,945,141 shares from the warrant programs Series 2011/2014 and series 2013/2016 where subscribed and paid for, which strengthens Brighter cash by MSEK 5.4 as of 2015-11-30.

|       Cash flow.

Cash flow from operations during the period January to September 2015 amounted to approx. SEK -5.6 (-4.3), from investment activities to approx. MSEK -9,0 (-11,2) and from financing activities to approx. MSEK +16.3 (+24.1).

The Company’s operating expenses consist mainly of rent, personnel expenses and other administrative expenses. The Company’s investments during the period consisted of mainly research & development and IP. Financing was exclusively acquired by the issuance of new shares in the two unit issues in April & May 2015.

|       Financial performance.

Net turnover for January to September 2015 was approx. SEK 0.0, unchanged from the previous year.

Operating income for the period was approx. MSEK -6.4 MSEK (-5.8).

The Company did not capitalize any costs during January. This due to the Board of Directors’ decision to abort the launch of Brighter One. Capitalization was resumed from February when the development of Actiste and the Benefit Loop was up to speed.

|       The share.

Brighter AB (publ) is listed on the NASDAQOMX First North exchange under the abbreviation BRIG. NASDAQOMX First North is a trading platform designated as an MTF (Multilateral Trading Facility). As of September 30 2015, 33,020,966 shares had been issued. All shares grant equal rights to the Company's profits and assets.

Brighter's Certified Advisor at NASDAQOMX First North is Remium Corporate Finance.

|       Development of the share capital.

Year Event Change in shares Change in share capital Total shares Total share capital Quota value
2007 Company creation - - 1,000,000 100,000.00 0.10
Aggregation -925,000 - 75,000 100,000.00 1.33
2011 Stock dividend issue 25,000 33,333.00 100,000 133,333.00 1.33
Stock dividend issue - 366,667.00 100,000 500,000.00 5.00
Split 9,900,000 - 10,000,000 500,000.00 0.05
2011 Rights issue 1,236,510 61,825.50 11,236,510 561,825.50 0.05
2012 Rights issue 660,971 33,048.55 11,897,481 594,874.05 0.05
2014 Rights issue 3,571,428 178,571.40 15,468,909 773,445.45 0.05
Rights issue 1,487,185 74,359.25 16,956,094 847,804.70 0.05
2015 Rights issue 13,564,872 678,243.60 30,520,966 1 526,048.30 0.05
2015 Oversubscription issue 2,500,000 125,000.00 33,020,966 1 651,048.30 0.05

|       Insiders’ holdings.

Shares. 2014-09-30 Change. 2015-09-30
Truls Sjöstedt – CEO 4,924,343 + 424,737 5,349,080
Gert Westergren – Chairman 380,386 + 125,000 505,386
Lars Flening – Board member 29,469 + 23,572 53,041
Henrik Norström - COO 48,838 + 389,124 448,150
Nadezda Ershova – Manager QA/RA 5,889  + 5,108 10,997
Afsaneh Ghatan Bauer – Board member 0 + 51,600 51,600
Petra Kaur Ljungman – Board member 0 +11,780 11,780
Sara Murby Forste – Board member 0 + 20,480 20,480
Jan Stålemark – Board member 0 0
Options. 2014-09-30 Change. 2015-09-30
Truls Sjöstedt – CEO 71,125 + 804,868 875,993
Gert Westergren – Chairman 537,459 + 153,250 690,709
Lars Flening – Board member 580,014 + 7,893 587,907
Henrik Norström - COO 0 + 716,251 716,251
Nadezda Ershova – Manager QA/RA 117,499 + 19,277 136,776
Afsaneh Ghatan Bauer – Board member 0 + 61,650 61,650
Petra Kaur Ljungman – Board member 12,500 + 6,945 19,445
Sara Murby Forste – Board member 12,500 + 72,620 85,120
Jan Stålemark – Board member 0 + 55,000 55,000

|       Income statement in thousands kronor in summary.

Thousand SEK. 2015-01-012015-09-30 2014-01-012014-09-30 2014-01-012014-12-31

Operating revenue. 1,583 1,233 1,758
Capitalization of development expenses 1,524 1,233 1,758
Other operating revenue. 59 0 0
Operating expenses. - 7,957 - 6,893 -24,192
Other external expenses. - 3,889 - 2,741 -4,024
Staff expenses. - 3,784 - 3,053 -4 544
Depreciation and amortization of tangible and intangible fixed. - 281 - 1,099 -15,624
Operating income. - 6,374 - 5,662 -22,434
Income from financial items. - 61 - 141 -7
Income after financial items. - 6,435 - 5,802 -22,441
Earnings. - 6,435 - 5,802 -22,441
Earnings per share, before dilution. -0.24 -0.22 -1,32
Earnings per share, after dilution. -0.24 -0.22 -1,32
Number of shares, before dilution. 33,020,966 16,956,094 16,956,094
Number of shares, after dilution. 41,348,295 18,149,706 19,267,205
Average number of shares, before dilution. 26,798,035 16,312,117 16,312,117
Average number of shares, after dilution. 35,125,364 17,505,729 18,623,228

|       Balance sheet in thousand kronor in summary.

Thousand SEK. 2015-09-30 2014-09-30 2014-12-31
ASSETS.
Fixed assets.                                                                 
Intangible assets. 16,542 18,407 8,511
Capitalized R&D and similar work. 503 663 622
Concessions, IP and similar rights. 250 50 50
Stock 646 0
Total fixed assets. 17,940 19,120 9,183
Current assets
Current receivables 1,198 1,089 942
Cash and bank balances. 5,243 8,478 3,686
Restricted funds. 208 259 256
Total current assets. 6,649 9,825 4,884
TOTAL ASSETS. 24,590 28,946 14,067
EQUITY AND LIABILITIES.
Equity.
Share capital. 1,651 848 848
Undistributed earnings / accumulated loss. 18,112 25,801 9,164
Total equity. 19,763 26,649 10,012
Short-term debt. 4,827 2,296 4,054
Accounts payable. 3,970 1,873 2,090
Other liabilities. 127 171 249
Accrued expenses. 730 252 1,715
TOTAL EQUITY AND LIABILITIES. 24,590 28,946 14,067
PLEDGES. 2,208 2,059 2,256
Restricted funds. 208 259 256
Corporate mortgages. 2,000 2,000 2,000
CONTINGENT LIABILITIES. None None None

|       Cash flow analysis in thousand kronor in summary.

2015-01-01 2014-01-01
2015-09-30 2014-09-30
Cash flow from operating activities before changes in in working capital - 6,154 - 4,709
Changes in working capital
Decrease/increase in current receivables - 256 - 588
Decrease/Increase in current liabilities 772 1,044
Cash flow from operating activities - 5,638 - 4,253
Investment activities
Acquisition of intangible fixed assets - 8,030 - 10,764
Acquisition of tangible fixed assets 0 - 369
Acquisition of financial assets. - 200 0
Acquisition of shares in subsidiaries.  0 - 50
Changes in stock. - 808 0
Cash flow from investment activities - 9,038 - 11,183
Financing activities
New share issue (net after issuing costs) 16,186 32,142
Change in restricted funds - 154 - 259
Loans taken 0 - 8,022
Amortizing of loans
Cash flow from financing activities 16,032 23,861
Cash flow for the period 1,510 8,683
Opening cash 3,942 -206
Closing cash. 5,451 8,478

|       Summary of changes in thousand kronor in equity.

Changes in equity 2015-01-01 2014-01-01 2014-01-01
2015-09-30 2014-09-30 2014-12-31
Opening equity 10,012 309 309
Profit for the period - 6,435 - 5,802 -22,438
New share issue (net after issuing costs). 16,186 32,142 32,144
Option payments. 0 0 0
Equity at end of period 19,763 26,642 10,012

|       Accounting principles.

This interim information has been prepared in accordance with the Swedish Annual Accounts Act and the Swedish Accounting Board’s Standards BFNAR 2012: 1 Annual and consolidated reporting.

Given that the subsidiary Brighter One AB has had no activity during the period and the no-cash issue for the acquisition of Division By Zero AB (Brighter Two AB) was not registered at the end of the period, no consolidated financial statements (Annual Accounts Act Chapter 7, § 3)

|       Auditors review.   

The Company’s auditors have not reviewed this interim information.

|       Certified Adviser.

Brighter's Certified Advisor at NASDAQOMX First North is Remium Corporate Finance.

Submission of interim information January – September 2015.

Stockholm November 30, 2015.

Brighter AB (publ).

Board of directors.

Questions? Please contact:

Henrik Norström, COO
Phone: 46 733 40 30 45
henrik.norstrom@brighter.se

Truls Sjöstedt, CEO
Phone: 46 709 73 46 00
truls.sjostedt@brighter.se

About Brighter AB (publ).

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and innovative tools, jDome® and Actiste™, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop ™, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

The Company's shares are listed on NASDAQOMX First North/BRIG.

Visit our website and subscribe to press releases: www.brighter.se/en.

Tags:

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.